Masataka Takekoshi

451 total citations
24 papers, 284 citations indexed

About

Masataka Takekoshi is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Masataka Takekoshi has authored 24 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in Masataka Takekoshi's work include Cytomegalovirus and herpesvirus research (7 papers), Amoebic Infections and Treatments (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Masataka Takekoshi is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Amoebic Infections and Treatments (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Masataka Takekoshi collaborates with scholars based in Japan and United States. Masataka Takekoshi's co-authors include Akira Yano, Seiji Ihara, Hiroshi Tachibana, Shinji Ihara, Yasuko Nagatsuka, Hideyuki Ihara, Xunjia Cheng, Satoshi Aotsuka, Hidetoshi Inoko and Katsuo Takahashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, European Journal of Immunology and Gene.

In The Last Decade

Masataka Takekoshi

24 papers receiving 272 citations

Peers

Masataka Takekoshi
Lauren Boucher United States
Stephanie Pollock United Kingdom
O Mach Czechia
Jennifer S. Lam United States
Masataka Takekoshi
Citations per year, relative to Masataka Takekoshi Masataka Takekoshi (= 1×) peers Anika Reinhardt

Countries citing papers authored by Masataka Takekoshi

Since Specialization
Citations

This map shows the geographic impact of Masataka Takekoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Takekoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Takekoshi more than expected).

Fields of papers citing papers by Masataka Takekoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Takekoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Takekoshi. The network helps show where Masataka Takekoshi may publish in the future.

Co-authorship network of co-authors of Masataka Takekoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Takekoshi. A scholar is included among the top collaborators of Masataka Takekoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Takekoshi. Masataka Takekoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takekoshi, Masataka, et al.. (2016). Quantitative evaluation of space structures defined by space syntax theory and categorized by indexes of compactness. Journal of the City Planning Institute of Japan. 51(3). 459–465. 1 indexed citations
2.
Komano, Jun, et al.. (2010). Inhibition of HIV replication by a CD4‐reactive Fab of an IgM clone isolated from a healthy HIV‐seronegative individual. European Journal of Immunology. 40(5). 1504–1509. 2 indexed citations
3.
Yano, Akira, Masataka Takekoshi, Eiko Morita, et al.. (2006). Production of Fab fragment corresponding to surface protein antigen of Streptococcus mutans serotype c-derived peptide by Escherichia coli and cultured tobacco cells. Journal of Bioscience and Bioengineering. 101(3). 251–256. 7 indexed citations
4.
Takekoshi, Masataka, Yasuko Nagatsuka, Satoshi Aotsuka, et al.. (2005). Production and characterization of recombinant human anti-HBs Fab antibodies. Journal of Virological Methods. 127(2). 141–147. 8 indexed citations
5.
Yano, Akira, et al.. (2004). Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen. Journal of Medical Virology. 73(2). 208–215. 36 indexed citations
6.
Tachibana, Hiroshi, et al.. (2004). Bacterial Expression of a Human Monoclonal Antibody-Alkaline Phosphatase Conjugate Specific for Entamoeba histolytica. Clinical and Vaccine Immunology. 11(1). 216–218. 11 indexed citations
7.
8.
Cheng, Xunjia, et al.. (2000). Bacterial Expression of a Human Monoclonal Antibody That Inhibits In Vitro Adherence of Entamoeba histolytica Trophozoites. Archives of Medical Research. 31(4). S311–S312. 1 indexed citations
9.
Ihara, Seiji, et al.. (2000). Entamoeba histolytica: Bacterial Expression of a Human Monoclonal Antibody Which Inhibits in Vitro Adherence of Trophozoites. Experimental Parasitology. 96(1). 52–56. 6 indexed citations
10.
Tachibana, Hiroshi, et al.. (1999). Bacterial expression of a neutralizing mouse monoclonal antibody Fab fragment to a 150-kilodalton surface antigen of Entamoeba histolytica.. American Journal of Tropical Medicine and Hygiene. 60(1). 35–40. 21 indexed citations
11.
Tachibana, Hiroshi, Xunjia Cheng, Masataka Takekoshi, et al.. (1999). Preparation of Recombinant Human Monoclonal Antibody Fab Fragments Specific forEntamoeba histolytica. Clinical and Diagnostic Laboratory Immunology. 6(3). 383–387. 13 indexed citations
12.
Nagatsuka, Yasuko, Hideyuki Ihara, Satoshi Aotsuka, et al.. (1999). Bacterial expression of a human recombinant monoclonal antibody Fab fragment against hepatitis B surface antigen. Journal of Medical Virology. 58(4). 338–345. 21 indexed citations
13.
Takekoshi, Masataka, Hiroshi Tachibana, Hidetoshi Inoko, et al.. (1998). Human monoclonal anti-HCMV neutralizing antibody from phage display libraries. Journal of Virological Methods. 74(1). 89–98. 25 indexed citations
14.
Ihara, Shinji, et al.. (1998). [Neutralizing human antibody specific for human cytomegalovirus in E. coli expression system].. PubMed. 56(1). 161–6. 1 indexed citations
15.
Ihara, Shinji, Masataka Takekoshi, Naoki Mori, et al.. (1994). Identification of mutation sites of a temperature-sensitive mutant of HCMV DNA polymerase activity. Archives of Virology. 137(3-4). 263–275. 7 indexed citations
16.
Takekoshi, Masataka, et al.. (1991). Site-specific stable insertion into the human cytomegalovirus genome of a foreign gene under control of the SV40 promoter. Gene. 101(2). 209–213. 14 indexed citations
17.
Takekoshi, Masataka, et al.. (1987). A New Human Cytomegalovirus Isolate Has an Invertible Subsegment within Its L Component Producing Eight Genome Isomers. Journal of General Virology. 68(3). 765–776. 14 indexed citations
18.
Ihara, Seiji, et al.. (1987). High-frequency transfection of mouse FM3A mammary carcinoma cells in suspension culture with plasmid DNA.. Cell Structure and Function. 12(6). 567–574. 2 indexed citations
19.
Ihara, Shinji, et al.. (1986). Cleavage maps of human cytomegalovirus genome (strain towne) determined by the use of cosmid cloning system. Archives of Virology. 88(3-4). 241–250. 5 indexed citations
20.
Takekoshi, Masataka, et al.. (1984). Transformation of human colostrum lymphocytes with Epstein-Barr virus and the production of IgA in culture.. PubMed. 9(2). 103–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026